ALUR
Allurion Technologies, Inc.
NYSE: ALUR · HEALTHCARE · MEDICAL DEVICES
$0.74
-0.03% today
Updated 2026-04-29
Market cap
$8.96M
P/E ratio
—
P/S ratio
0.52x
EPS (TTM)
$-16.20
Dividend yield
—
52W range
$0 – $4
Volume
3.2M
Allurion Technologies, Inc. (ALUR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.74
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$4.94
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -1.88%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.